AstraZeneca and Oxford University announced they had "voluntarily paused" their vaccine trial after a UK volunteer developed an unexplained illness.But on Saturday the trial was given the all clear by British regulators to resume following a safety review.
The company also announced it was resuming clinical trials in Brazil next Monday after being given the green light there as well.The global death toll from the coronavirus has risen to 916,000 with 28.5 million infections, while France and the United Arab Emirates posted grim new milestones for daily infections on Saturday.And with billions still suffering from the fallout of the pandemic, a worldwide race for a vaccine is underway, with nine companies already in late-stage Phase 3.